Global Hospital-Acquired Infection Control Market Size, Status and Forecast 2020-2026

HAI is a term used to describe all infections that do not stem from the patient’s original diagnosis on admission.
HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.

Market Analysis and Insights: Global Hospital-Acquired Infection Control Market
The global Hospital-Acquired Infection Control market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hospital-Acquired Infection Control Scope and Market Size
Hospital-Acquired Infection Control market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Infection Control market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group

Market segment by Type, the product can be split into

Catheter-associated Urinary Tract Infections (CAUTIs)
Surgical Site Infections (SSIs)
Central Line-associated Bloodstream Infections (CLABSIs)
Respiratory Infections

Market segment by Application, split into

Hospitals and ICUs
Outpatient Care Centers
Long-term Care Facilities (LTCFs)

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India